跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Condesaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Condesaph
Approved
STANDARD
Condesaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
599f767b7874ed4d
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
599f767b7874ed4d
Drug Approval Philippines Name
Condesaph
Product Name
Condesaph
Registration Number
DRP-16649
Brand Name
Condesaph
Generic Name
Paracetamol + Phenylephrine Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg/5 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc,
Distributor
Nelpa Lifesciences, Inc,
Issuance Date
29 May 2025
Expiry Date
29 May 2030
Pharmacologic Category
Analgesic/ Antipyretic/ Nasal Decongestant
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
599f767b7874ed4d
Type
Standard
Back to Philippines FDA Approvals